Vaccination

Increase in hepatitis A vaccination needed to prevent deaths

Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4% have evidence of vaccination, according to research published in the Oct. 20 issue ...

Diseases, Conditions, Syndromes

New care model delivers hepatitis C treatment to most vulnerable

Breakthrough treatments introduced over the last decade have transformed hepatitis C from a chronic and potentially deadly infectious disease into one that can be cured. But these medications have often been beyond the reach ...

Oncology & Cancer

Liver cancer: Risk factors and prevention

October is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you can do to prevent it.

Diseases, Conditions, Syndromes

Q&A: Expert discusses prevalence of hepatitis C in US state prisons

The World Health Organization has a goal to eliminate hepatitis C as a public health threat by 2030. The blood-borne virus affects more than 2 million people in the United States and killed more than 15,700 people nationwide ...

HIV & AIDS

Advancing care for people with HIV and hepatitis C

A team of researchers across Yale School of Medicine (YSM) and the University of Texas Health Science Center at San Antonio (UTHSCSA) has published a set of papers on innovations in patient care for those diagnosed with hepatitis ...

page 3 from 40